MARATTO

article · Transplantation and Cellular Therapy

Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicity

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Hematopoietic Stem Cell Transplantation
  • Polyomavirus and related diseases
  • Cytomegalovirus and herpesvirus research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.jtct.2026.06.038

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.